We conclude that hyperglycemia leads to enhanced cell proliferation and cytoskeleton flexibility via promoting actin de-polymerization, and thus endows CRC cells with higher metastatic potential by downregulating CRMP2 profile and contributes to CRC disease progression. The gene discussed is DPYSL2; the disease is colorectal carcinoma.